Inhibition of indoleamine 2,3-dioxygenase activity accelerates skin wound healing

Biomaterials

Volumn 53, Issue , 2015, Pages 221-228

  Ito, Hiroyasu ^a   Ando, Tatsuya ^a   Ogiso, Hideyuki ^a   Arioka, Yuko ^a   Saito, Kuniaki ^b   Seishima, Mitsuru ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amino acid; Animal model; Cytokine; Inflammation; Wound closure; Wound healing

Indexed keywords

AMINO ACIDS; MAMMALS; PATHOLOGY;

ANIMAL MODEL; CYTOKINES; INFLAMMATION; WOUND CLOSURE; WOUND HEALING;

TISSUE REGENERATION;

INDOLEAMINE 2,3 DIOXYGENASE; MESSENGER RNA; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; GENE; GENE EXPRESSION; IDO1 GENE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN INJURY; SKIN WOUND HEALING; UPREGULATION; WILD TYPE MOUSE; WOUND HEALING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; GENETICS; INJURIES; METABOLISM; SKIN;

ANIMALIA; MUS;

ANIMALS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SKIN; WOUND HEALING;

EID: 84927925576     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.02.098     Document Type: Article

References (29)

1. Singer A.J., Clark R.A. Cutaneous wound healing. NEngl J Med 1999, 341:738-746.
2. Gallucci R.M., Simeonova P.P., Matheson J.M., Kommineni C., Guriel J.L., Sugawara T., et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J Off Publ Fed Am Soc Exp Biol 2000, 14:2525-2531.
3. Freedberg I.M., Tomic-Canic M., Komine M., Blumenberg M. Keratins and the keratinocyte activation cycle. JInvest Dermatol 2001, 116:633-640.
4. Tang A., Gilchrest B.A. Regulation of keratinocyte growth factor gene expression in human skin fibroblasts. JDermatol Sci 1996, 11:41-50.
5. Murray H.W., Szuro-Sudol A., Wellner D., Oca M.J., Granger A.M., Libby D.M., et al. Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages. Infect Immun 1989, 57:845-849.
6. Ito H., Hoshi M., Ohtaki H., Taguchi A., Ando K., Ishikawa T., et al. Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model. JImmunol 2010, 185:4554-4560.
7. Durr S., Kindler V. Implication of indolamine 2,3 dioxygenase in the tolerance toward fetuses, tumors, and allografts. JLeukoc Biol 2013, 93:681-687.
8. Hoshi M., Ito H., Fujigaki H., Takemura M., Takahashi T., Tomita E., et al. Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity. Leukemia Res 2009, 33:39-45.
9. Hoshi M., Matsumoto K., Ito H., Ohtaki H., Arioka Y., Osawa Y., et al. L-tryptophan-kynurenine pathway metabolites regulate type I IFNs of acute viral myocarditis in mice. JImmunol 2012, 188:3980-3987.
10. Iwamoto N., Ito H., Ando K., Ishikawa T., Hara A., Taguchi A., et al. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes invivo. Liver Int Off J Int Assoc Study Liver 2009, 29:277-283.
11. Ito H., Ando T., Ando K., Ishikawa T., Saito K., Moriwaki H., et al. Induction of hepatitis B virus surface antigen-specific cytotoxic T lymphocytes can be up-regulated by the inhibition of indoleamine 2, 3-dioxygenase activity. Immunology 2014, 142:614-623.
12. Fujigaki H., Saito K., Fujigaki S., Takemura M., Sudo K., Ishiguro H., et al. The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines. JBiochem 2006, 139:655-662.
13. Munn D.H., Shafizadeh E., Attwood J.T., Bondarev I., Pashine A., Mellor A.L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. JExp Med 1999, 189:1363-1372.
14. Fallarino F., Grohmann U., Vacca C., Bianchi R., Orabona C., Spreca A., et al. Tcell apoptosis by tryptophan catabolism. Cell Death Differ 2002, 9:1069-1077.
15. Terness P., Bauer T.M., Rose L., Dufter C., Watzlik A., Simon H., et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. JExp Med 2002, 196:447-457.
16. Hoshi M., Osawa Y., Ito H., Ohtaki H., Ando T., Takamatsu M., et al. Blockade of indoleamine 2,3-dioxygenase reduces mortality from peritonitis and sepsis in mice by regulating functions of CD11b+ peritoneal cells. Infect Immun 2014, 82:4487-4495.
17. O'Callaghan-Sunol C., Sherman M.Y. Heat shock transcription factor (HSF1) plays a critical role in cell migration via maintaining MAP kinase signaling. Cell Cycle 2006, 5:1431-1437.
18. Getty A.L., Benedict J.W., Pearce D.A. Anovel interaction of CLN3 with nonmuscle myosin-IIB and defects in cell motility of Cln3(-/-) cells. Exp cell Res 2011, 317:51-69.
19. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regeneration Off Publ Wound Heal Soc Eur Tissue Repair Soc 2008, 16:585-601.
20. Kyriakides T.R., Wulsin D., Skokos E.A., Fleckman P., Pirrone A., Shipley J.M., et al. Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. Matrix Biol J Int Soc Matrix Biol 2009, 28:65-73.
21. Eming S.A., Krieg T., Davidson J.M. Inflammation in wound repair: molecular and cellular mechanisms. JInvestigative Dermatol 2007, 127:514-525.
22. Hoshi M., Saito K., Hara A., Taguchi A., Ohtaki H., Tanaka R., et al. The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouse. JImmunol 2010, 185:3305-3312.
23. Ohtaki H., Ito H., Ando K., Ishikawa T., Hoshi M., Ando T., et al. Kynurenine production mediated by indoleamine 2,3-dioxygenase aggravates liver injury in HBV-specific CTL-induced fulminant hepatitis. Biochimica Biophysica Acta 2014, 1842:1464-1471.
24. Saito K., Markey S.P., Heyes M.P. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience 1992, 51:25-39.
25. Celinski K., Konturek S.J., Konturek P.C., Brzozowski T., Cichoz-Lach H., Slomka M., et al. Melatonin or L-tryptophan accelerates healing of gastroduodenal ulcers in patients treated with omeprazole. JPineal Res 2011, 50:389-394.
26. Konturek P.C., Konturek S.J., Celinski K., Slomka M., Cichoz-Lach H., Bielanski W., et al. Role of melatonin in mucosal gastroprotection against aspirin-induced gastric lesions in humans. JPineal Res 2010, 48:318-323.
27. Pugazhenthi K., Kapoor M., Clarkson A.N., Hall I., Appleton I. Melatonin accelerates the process of wound repair in full-thickness incisional wounds. JPineal Res 2008, 44:387-396.
28. Brauchle M., Angermeyer K., Hubner G., Werner S. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 1994, 9:3199-3204.
29. Low Q.E., Drugea I.A., Duffner L.A., Quinn D.G., Cook D.N., Rollins B.J., et al. Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. Am J Pathol 2001, 159:457-463.